Boehringer Ingelheim
For Healthcare Professionals

Document ID: PC-MY-101817

Speaker: Assoc Prof Dr Ho Gwo-Fuang

PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)

Watch Assoc Prof. Dr Ho Gwo Fuang share his insights on the significance of personalizing the approach with targeted EGFR-TKI therapy in lung adenocarcinoma during the 2021 Best of ASCO meeting symposium session ‘PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)'

Expert Conversations

Malaysia Region Tumour Heterogeneity in Lung Cancer Asian setting
MYEEE||EGFR TKI-related Dermatological Adverse Events
MYEEE||Evidence for Sequential Therapy in EGFR M+ NSCLC
MYEEE||Effectiveness of Dose Modification Strategies with Afatinib
MYEEE||Strategies in Managing EGFRM+ NSCLC
Malaysia Region Treatment stratergy with EGFR-TKIs Asian setting
Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Q&A session)
Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Presentation)
MYEEE||PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)
Uncovering the Uncommon: Efficacy of Afatinib in Uncommon and Compound Mutations
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Q&A)

Speaker

my-speaker-Assoc-Prof-Dr-Ho-Gwo-Fuang.png

Assoc Prof Dr Ho Gwo Fuang

Associate Professor Clinical Oncologist/Radiotherapist University Malaya Medical Centre University Malaya Specialist Centre Kuala Lumpur, Malaysia

RELATED CONTENT